Delivery Order SPE2DE21D7020-SPE2D625F1QFY
- Not listed
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,402.62 by the Defense Health Agency's Medical Supply Chain for AMPLATZ SS 75cm .035 medical devices (5-pack units). This fixed-price delivery order with economic price adjustment was awarded on July 24, 2025, with an ultimate completion date of July 31, 2025. The contract carries no set-aside designation, indicating open competition in the federal marketplace. The place of...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $2,157.35 by the Defense Health Agency's Medical Supply Chain on August 19, 2025. The contract covers a Selective MC Single Bern 130CM medical device and carries an ultimate completion date of August 26, 2025. This fixed-price delivery order with economic price adjustment represents one of numerous federal contract awards Boston Scientific...
- Boston Scientific Corp was awarded a $4,572.88 delivery order on September 4, 2025, for AMPLATZ SS 75cm .035 medical devices (quantity: 5 units) under a fixed-price contract with economic price adjustment provisions. The award has an ultimate completion date of September 11, 2025, and is performed at Boston Scientific's Marlborough, Massachusetts facility. This delivery order was issued through the Defense Health Agency's Medical Supply Chain, a defense-focused federal healthcare procurement...
- Boston Scientific Corp has been awarded a delivery order valued at $8,504.42 for AMPLATZ S/S XCH/035/260 (BX/5) medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside procurement through the Defense Health Agency's Medical Supply Chain. The place of performance is Boston Scientific's facility in Marlborough, Massachusetts, where the company...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $12,317.30 by the Defense Health Agency's Medical Supply Chain division. The delivery order, designated as a non-set-aside contract with an ultimate completion date of August 27, 2025, represents a continuation of Boston Scientific's role as a critical supplier of advanced medical devices to federal healthcare agencies. The contract is...
- Boston Scientific Corp has been awarded a delivery order valued at $4,717.19 by the Defense Health Agency's Medical Supply Chain for AMPLATZ SS 035/260/1 (BX/5) medical devices. This fixed-price contract with economic price adjustment was awarded on August 6, 2025, with an ultimate completion date of August 13, 2025. The order will be performed at Boston Scientific's facility in Marlborough, Massachusetts, and represents a non-set-aside award in the competitive federal marketplace. This delivery...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,050.68 by the Defense Health Agency's Medical Supply Chain program. The contract, issued on August 4, 2025, with an ultimate completion date of August 11, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. The place of performance is Boston Scientific's facility in Marlborough,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order with economic price adjustment valued at $4,860 by the Defense Health Agency's Medical Supply Chain division on September 2, 2025. The delivery order, with an ultimate completion date of September 9, 2025, represents a short-duration task order for specialized medical devices or equipment. As a major federal contractor, Boston Scientific supplies...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F1QFYDelivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $1,750.75 for AMPLATZ SS 035/260/1 (BX/5) medical devices. The contract, awarded on August 21, 2025, with an ultimate completion date of August 28, 2025, utilizes fixed-price pricing with economic price adjustment provisions. This delivery order was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The place of performance is located in Marlborough, MA, where the company maintains its headquarters and primary operations for medical device manufacturing and distribution. The contract is funded through the Medical Supply Chain, a defense-oriented federal agency that procures advanced medical technologies for military and defense healthcare systems. Boston Scientific's extensive portfolio of federal contracts demonstrates its critical role as a supplier of specialized medical devices, including cardiovascular intervention tools, stents, and diagnostic equipment to agencies such as the Defense Health Agency and Defense Logistics Agency. This delivery order represents a continuation of the company's ongoing provision of innovative medical technologies to support federal healthcare operations and readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/21/25 |